Plain-English translation of ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach called single-dose radiotherapy (SDRT) for men with early-stage prostate cancer. Instead of receiving multiple radiation sessions over weeks, you would receive one carefully planned, high-dose radiation treatment delivered with advanced imaging and special immobilization devices to keep your prostate in the exact same position and protect surrounding healthy tissue. Recent research suggests this single-treatment approach may work as well as traditional multi-session radiation therapy, but with much greater convenience.
Standard prostate cancer radiation requires multiple sessions over several weeks, which is time-consuming and burdensome for patients. Earlier trials showed that a single high-dose treatment may be just as effective with fewer side effects, but more research is needed to confirm this approach is safe and works reliably in clinical practice.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive careful planning scans and imaging to map your prostate precisely. On treatment day, a small air-filled balloon will be placed in your rectum and a catheter in your urethra to keep your prostate in the exact position during treatment. You will then receive a single, focused high-dose radiation beam delivered by advanced imaging-guided equipment, and the entire process takes about 30 minutes to an hour. After treatment, you will have follow-up visits to monitor for side effects and to confirm the treatment is working.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Russia